187
Views
6
CrossRef citations to date
0
Altmetric
Drug Profile

Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Hong-Ru Dong, Jian-Guo Wu & Guo-Yong Huo. (2022) Design, synthesis and biological studies of some new imidazole-1,2,3-triazole hybrid derivatives. Journal of Molecular Structure 1256, pages 132516.
Crossref
Nabil A. Alhakamy, Shadab Md, Md Shoaib Alam, Rasheed A. Shaik, Javed Ahmad, Abrar Ahmad, Hussam I. Kutbi, Ahmad O. Noor, Alaa Bagalagel, Douha F. Bannan, Bapi Gorain & Ponnurengam Malliappan Sivakumar. (2021) Development, Optimization, and Evaluation of Luliconazole Nanoemulgel for the Treatment of Fungal Infection. Journal of Chemistry 2021, pages 1-13.
Crossref
Sebastian Gnat, Mariusz Dyląg, Dominik Łagowski & Jessica Zielinski. (2021) Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams. Mycoses 64:8, pages 967-975.
Crossref
GaneshN Dakhale, AshishV Gupta, JayeshI Mukhi & MrunaliniV Kalikar. (2021) Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study. Perspectives in Clinical Research 12:4, pages 223.
Crossref
Samuel Yeroushalmi, Joshua Yoseph Shirazi & Adam Friedman. (2020) New Developments in Bacterial, Viral, and Fungal Cutaneous Infections. Current Dermatology Reports 9:2, pages 152-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.